ArticleBone marrow transplantation2022

Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.

Laure Vincent et al.PubMed ↗Publisher ↗

No numbers read from the abstract.